Tag Archives: rimonabant
July 2008 Br J Cardiol 2008;15:185-88
News
BJCardio editorial team
New data on intensive glucose lowering in type 2 diabetes The results of three large trials investigating the clinical effects of intensive glucose lowering in patients with type II diabetes were presented at the recent American Diabetes Association meeting in San Francisco, USA, and have shown somewhat conflicting results. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial was stopped earlier this year because of an increased mortality in the intensive glucose lowering group. The two other trials – ADVANCE (Action in Diabetes and Vascular Disease – Preterax and Diamicron MR Controlled Evaluation) and VADT (Veteran’s A
March 2006 Br J Cardiol 2006;13:90-8
American College of Cardiology 55th Annual Scientific Session
BJCardio editorial team
No content available
For healthcare professionals only
